Invention Application
US20080004295A1 NOVEL COMPOUNDS 审中-公开
新型化合物

NOVEL COMPOUNDS
Abstract:
Pyrrolopyrimidine derivatives of formula (I) are inhibitors of Spleen Tyrosine kinase (Syk) and therefore of potential therapeutic benefit in the treatment of diseases and conditions associated with inappropriate Syk activity, in particular in the treatment of inflammatory and allergic diseases.
Information query
Patent Agency Ranking
0/0